199 related articles for article (PubMed ID: 37106426)
1. Semi-automated optimized method to isolate CRISPR/Cas9 edited human pluripotent stem cell clones.
Frank E; Cailleret M; Nelep C; Fragner P; Polentes J; Herardot E; El Kassar L; Giraud-Triboult K; Monville C; Ben M'Barek K
Stem Cell Res Ther; 2023 Apr; 14(1):110. PubMed ID: 37106426
[TBL] [Abstract][Full Text] [Related]
2. A Cell-Based Optimised Approach for Rapid and Efficient Gene Editing of Human Pluripotent Stem Cells.
Cuevas-Ocaña S; Yang JY; Aushev M; Schlossmacher G; Bear CE; Hannan NRF; Perkins ND; Rossant J; Wong AP; Gray MA
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373413
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Protocols for CRISPR/Cas9-based Gene Editing in Human Pluripotent Stem Cells.
Santos DP; Kiskinis E; Eggan K; Merkle FT
Curr Protoc Stem Cell Biol; 2016 Aug; 38():5B.6.1-5B.6.60. PubMed ID: 27532820
[TBL] [Abstract][Full Text] [Related]
4. Methods for Automated Single Cell Isolation and Sub-Cloning of Human Pluripotent Stem Cells.
Vallone VF; Telugu NS; Fischer I; Miller D; Schommer S; Diecke S; Stachelscheid H
Curr Protoc Stem Cell Biol; 2020 Dec; 55(1):e123. PubMed ID: 32956572
[TBL] [Abstract][Full Text] [Related]
5. Pipeline for the Generation and Characterization of Transgenic Human Pluripotent Stem Cells Using the CRISPR/Cas9 Technology.
Mianné J; Bourguignon C; Nguyen Van C; Fieldès M; Nasri A; Assou S; De Vos J
Cells; 2020 May; 9(5):. PubMed ID: 32466123
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish.
González F
Dev Dyn; 2016 Jul; 245(7):788-806. PubMed ID: 27145095
[TBL] [Abstract][Full Text] [Related]
7. A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease.
Hazelbaker DZ; Beccard A; Bara AM; Dabkowski N; Messana A; Mazzucato P; Lam D; Manning D; Eggan K; Barrett LE
Stem Cell Reports; 2017 Oct; 9(4):1315-1327. PubMed ID: 29020615
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-based Targeted Genome Editing for the Development of Monogenic Diseases Models with Human Pluripotent Stem Cells.
Gupta N; Susa K; Yoda Y; Bonventre JV; Valerius MT; Morizane R
Curr Protoc Stem Cell Biol; 2018 May; 45(1):e50. PubMed ID: 30040245
[TBL] [Abstract][Full Text] [Related]
9. TALEN- and CRISPR/Cas9-Mediated Gene Editing in Human Pluripotent Stem Cells Using Lipid-Based Transfection.
Hendriks WT; Jiang X; Daheron L; Cowan CA
Curr Protoc Stem Cell Biol; 2015 Aug; 34():5B.3.1-5B.3.25. PubMed ID: 26237572
[TBL] [Abstract][Full Text] [Related]
10. Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content Screening.
Vojnits K; Nakanishi M; Porras D; Kim Y; Feng Z; Golubeva D; Bhatia M
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458632
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9-Mediated Gene Editing in Salmonids Cells and Efficient Establishment of Edited Clonal Cell Lines.
Strømsnes TAH; Schmidke SE; Azad M; Singstad Ø; Grønsberg IM; Dalmo RA; Okoli AS
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555862
[TBL] [Abstract][Full Text] [Related]
12. Generating CRISPR-Cas9-Mediated Null Mutations and Screening Targeting Efficiency in Human Pluripotent Stem Cells.
Bower OJ; McCarthy A; Lea RA; Alanis-Lobato G; Zohren J; Gerri C; Turner JMA; Niakan KK
Curr Protoc; 2021 Aug; 1(8):e232. PubMed ID: 34432381
[TBL] [Abstract][Full Text] [Related]
13. Highly efficient generation of isogenic pluripotent stem cell models using prime editing.
Li H; Busquets O; Verma Y; Syed KM; Kutnowski N; Pangilinan GR; Gilbert LA; Bateup HS; Rio DC; Hockemeyer D; Soldner F
Elife; 2022 Sep; 11():. PubMed ID: 36069759
[TBL] [Abstract][Full Text] [Related]
14. Efficient scarless genome editing in human pluripotent stem cells.
Ikeda K; Uchida N; Nishimura T; White J; Martin RM; Nakauchi H; Sebastiano V; Weinberg KI; Porteus MH
Nat Methods; 2018 Dec; 15(12):1045-1047. PubMed ID: 30504872
[TBL] [Abstract][Full Text] [Related]
15. Scarless Genome Editing of Human Pluripotent Stem Cells via Transient Puromycin Selection.
Steyer B; Bu Q; Cory E; Jiang K; Duong S; Sinha D; Steltzer S; Gamm D; Chang Q; Saha K
Stem Cell Reports; 2018 Feb; 10(2):642-654. PubMed ID: 29307579
[TBL] [Abstract][Full Text] [Related]
16. Improving single-cell cloning workflow for gene editing in human pluripotent stem cells.
Chen YH; Pruett-Miller SM
Stem Cell Res; 2018 Aug; 31():186-192. PubMed ID: 30099335
[TBL] [Abstract][Full Text] [Related]
17. BIG-TREE: Base-Edited Isogenic hPSC Line Generation Using a Transient Reporter for Editing Enrichment.
Brookhouser N; Tekel SJ; Standage-Beier K; Nguyen T; Schwarz G; Wang X; Brafman DA
Stem Cell Reports; 2020 Feb; 14(2):184-191. PubMed ID: 32004495
[TBL] [Abstract][Full Text] [Related]
18. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.
Merkle FT; Neuhausser WM; Santos D; Valen E; Gagnon JA; Maas K; Sandoe J; Schier AF; Eggan K
Cell Rep; 2015 May; 11(6):875-883. PubMed ID: 25937281
[TBL] [Abstract][Full Text] [Related]
19. Protocol for the Generation of Human Pluripotent Reporter Cell Lines Using CRISPR/Cas9.
Zhong A; Li M; Zhou T
STAR Protoc; 2020 Sep; 1(2):. PubMed ID: 33073252
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-Mediated Genome Editing to Generate Clonal iPSC Lines.
Sanjurjo-Soriano C; Erkilic N; Mamaeva D; Kalatzis V
Methods Mol Biol; 2022; 2454():589-606. PubMed ID: 33755901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
